Evidence map›Paper›PMID 41192947›Full record

ArticleBMJ mental health2025

Temporal relationship between severe mental illness and neurological conditions in a UK primary care cohort.

Ella Burchill, Jonathan P Rogers, David P J Osborn, Glyn Lewis, Anthony S David, Joseph F Hayes, Naomi Launders

Abstract read
In one paragraph

Article in BMJ mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ella BurchillDivision of Psychiatry, University College London, London, UK.ORCID 0000-0002-1674-8844
Jonathan P RogersDivision of Psychiatry, University College London, London, UK jonathan.rogers@ucl.ac.uk.ORCID 0000-0002-4671-5410
David P J OsbornDivision of Psychiatry, University College London, London, UK.ORCID 0000-0003-2519-1539
Glyn LewisDivision of Psychiatry, University College London, London, UK.ORCID 0000-0001-5205-8245
Anthony S DavidInstitute of Mental Health, Division of Psychiatry, University College London Faculty of Brain Sciences, London, UK.ORCID 0000-0003-0967-774X
Joseph F HayesDivision of Psychiatry, University College London, London, UK.ORCID 0000-0003-2286-3862
Naomi LaundersDivision of Psychiatry, University College London, London, UK.ORCID 0000-0003-4241-938X

Funding

Medical Research Council & British Heart Foundation & Cancer Research UK MR/W014386/1NIHR National Institute of Health Research CL-2023-18-002Wellcome Trust 220659/Z/20/Z
6 · The paper itself

Abstract

backgroundA higher prevalence of neurological conditions has been found in schizophrenia, bipolar disorder and other psychotic illnesses compared to the general population. We aimed to understand the cumulative prevalence of 15 neurological conditions in people with severe mental illness (SMI) from 5 years before to 5 years after their SMI diagnosis.

methodsWe identified patients with SMI, aged 18-100 years from 1 Jan 2000 to 31 Dec 2018, from the UK Clinical Practice Research Datalink. Each SMI patient was matched 1:4 to individuals without SMI. The cumulative prevalence of 15 neurological conditions was recorded at 5, 3 and 1 years prior to SMI diagnosis; at SMI diagnosis; and 1, 3 and 5 years after SMI diagnosis. Prevalences were compared with logistic regression.

resultsWe identified 68 789 patients with SMI and 274 827 comparators. Of 15 neurological conditions, 13 (multiple sclerosis, cerebrovascular disease, dementia, ataxic disorders, epilepsy, Parkinson's disease, other parkinsonism, paralysis, other movement disorders, cerebrospinal fluid disorders, cerebral palsy, disorders of nerve root, plexus or peripheral nerves and autonomic disorders) were more prevalent in SMI compared with comparators at the time of SMI diagnosis. Dementia (OR: 4.22; 95% CI 3.88 to 4.58), epilepsy (OR: 3.01; 95% CI 2.83 to 3.19) and Parkinson's disease (OR: 3.97; 95% CI 3.45 to 4.57) were particularly elevated at 5 years post-SMI diagnosis.

conclusionsMany neurological conditions have higher prevalence in the SMI cohort compared with those without SMI. The different prevalence patterns observed in our study highlight the need to establish the causal pathways between specific SMI and neurological disease diagnoses.

Indexed as

Mental DisordersNervous System DiseasesPrimary Health CareAdolescentAdultAgedAged, 80 and overCohort StudiesComorbidityFemaleHumansMaleMiddle AgedPrevalenceUnited KingdomYoung AdultAffective Disorders, PsychoticBipolar and Related DisordersNeurocognitive DisordersSchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders

Identifiers

PMID41192947
PMCPMC12587905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.